nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—HTR2C—choroid plexus—malignant glioma	0.0664	0.13	CbGeAlD
Methotrimeprazine—DRD3—telencephalic ventricle—malignant glioma	0.035	0.0686	CbGeAlD
Methotrimeprazine—HTR2A—choroid plexus—malignant glioma	0.0333	0.0654	CbGeAlD
Methotrimeprazine—DRD1—telencephalic ventricle—malignant glioma	0.0251	0.0491	CbGeAlD
Methotrimeprazine—HTR2C—telencephalic ventricle—malignant glioma	0.0195	0.0382	CbGeAlD
Methotrimeprazine—HTR2A—cerebellar cortex—malignant glioma	0.0168	0.0329	CbGeAlD
Methotrimeprazine—DRD2—telencephalic ventricle—malignant glioma	0.0148	0.029	CbGeAlD
Methotrimeprazine—HTR2A—pons—malignant glioma	0.0119	0.0233	CbGeAlD
Methotrimeprazine—HTR2A—vertebral column—malignant glioma	0.0118	0.0231	CbGeAlD
Methotrimeprazine—HTR2A—telencephalic ventricle—malignant glioma	0.00976	0.0192	CbGeAlD
Methotrimeprazine—HTR2A—pineal body—malignant glioma	0.00847	0.0166	CbGeAlD
Methotrimeprazine—DRD5—telencephalon—malignant glioma	0.00787	0.0154	CbGeAlD
Methotrimeprazine—Trifluoperazine—CALY—malignant glioma	0.00778	0.329	CrCbGaD
Methotrimeprazine—DRD1—brainstem—malignant glioma	0.00678	0.0133	CbGeAlD
Methotrimeprazine—ADRA1D—telencephalon—malignant glioma	0.00631	0.0124	CbGeAlD
Methotrimeprazine—DRD1—telencephalon—malignant glioma	0.00602	0.0118	CbGeAlD
Methotrimeprazine—DRD4—brain—malignant glioma	0.00539	0.0106	CbGeAlD
Methotrimeprazine—HTR2C—brainstem—malignant glioma	0.00527	0.0103	CbGeAlD
Methotrimeprazine—HTR2A—endothelium—malignant glioma	0.00524	0.0103	CbGeAlD
Methotrimeprazine—CHRM4—central nervous system—malignant glioma	0.00514	0.0101	CbGeAlD
Methotrimeprazine—CHRM2—telencephalon—malignant glioma	0.00485	0.00951	CbGeAlD
Methotrimeprazine—HTR2A—blood vessel—malignant glioma	0.00483	0.00948	CbGeAlD
Methotrimeprazine—DRD3—central nervous system—malignant glioma	0.00478	0.00937	CbGeAlD
Methotrimeprazine—HTR2C—telencephalon—malignant glioma	0.00467	0.00917	CbGeAlD
Methotrimeprazine—DRD5—central nervous system—malignant glioma	0.00448	0.00878	CbGeAlD
Methotrimeprazine—CHRM1—telencephalon—malignant glioma	0.00441	0.00866	CbGeAlD
Methotrimeprazine—DRD1—midbrain—malignant glioma	0.00432	0.00847	CbGeAlD
Methotrimeprazine—ADRA1A—brainstem—malignant glioma	0.00409	0.00801	CbGeAlD
Methotrimeprazine—CHRM4—brain—malignant glioma	0.00408	0.008	CbGeAlD
Methotrimeprazine—CHRM5—central nervous system—malignant glioma	0.00402	0.00788	CbGeAlD
Methotrimeprazine—DRD2—brainstem—malignant glioma	0.00401	0.00786	CbGeAlD
Methotrimeprazine—CHRM3—telencephalon—malignant glioma	0.00395	0.00775	CbGeAlD
Methotrimeprazine—DRD2—retina—malignant glioma	0.00386	0.00758	CbGeAlD
Methotrimeprazine—DRD3—brain—malignant glioma	0.00379	0.00744	CbGeAlD
Methotrimeprazine—HTR2C—medulla oblongata—malignant glioma	0.00367	0.0072	CbGeAlD
Methotrimeprazine—ADRA1B—central nervous system—malignant glioma	0.00367	0.0072	CbGeAlD
Methotrimeprazine—ADRA1A—telencephalon—malignant glioma	0.00363	0.00711	CbGeAlD
Methotrimeprazine—ADRA1D—central nervous system—malignant glioma	0.00359	0.00704	CbGeAlD
Methotrimeprazine—DRD2—telencephalon—malignant glioma	0.00355	0.00697	CbGeAlD
Methotrimeprazine—DRD5—brain—malignant glioma	0.00355	0.00697	CbGeAlD
Methotrimeprazine—ADRA2C—telencephalon—malignant glioma	0.00346	0.00678	CbGeAlD
Methotrimeprazine—DRD1—central nervous system—malignant glioma	0.00342	0.00671	CbGeAlD
Methotrimeprazine—HTR2C—midbrain—malignant glioma	0.00336	0.00658	CbGeAlD
Methotrimeprazine—HTR2C—spinal cord—malignant glioma	0.00327	0.00642	CbGeAlD
Methotrimeprazine—CHRM5—brain—malignant glioma	0.00319	0.00625	CbGeAlD
Methotrimeprazine—ADRA1B—brain—malignant glioma	0.00291	0.00571	CbGeAlD
Methotrimeprazine—HTR2A—embryo—malignant glioma	0.00288	0.00565	CbGeAlD
Methotrimeprazine—ADRA1D—brain—malignant glioma	0.00285	0.00559	CbGeAlD
Methotrimeprazine—HRH1—telencephalon—malignant glioma	0.00281	0.00551	CbGeAlD
Methotrimeprazine—ADRA2A—telencephalon—malignant glioma	0.00276	0.00541	CbGeAlD
Methotrimeprazine—CHRM2—central nervous system—malignant glioma	0.00276	0.00541	CbGeAlD
Methotrimeprazine—ADRA2C—medulla oblongata—malignant glioma	0.00272	0.00533	CbGeAlD
Methotrimeprazine—DRD1—brain—malignant glioma	0.00271	0.00533	CbGeAlD
Methotrimeprazine—CYP2E1—telencephalon—malignant glioma	0.0027	0.00529	CbGeAlD
Methotrimeprazine—HTR2C—central nervous system—malignant glioma	0.00266	0.00521	CbGeAlD
Methotrimeprazine—HTR2A—brainstem—malignant glioma	0.00264	0.00518	CbGeAlD
Methotrimeprazine—DRD2—midbrain—malignant glioma	0.00255	0.00501	CbGeAlD
Methotrimeprazine—HTR2A—retina—malignant glioma	0.00255	0.005	CbGeAlD
Methotrimeprazine—CHRM1—central nervous system—malignant glioma	0.00251	0.00492	CbGeAlD
Methotrimeprazine—ADRA2C—midbrain—malignant glioma	0.00248	0.00487	CbGeAlD
Methotrimeprazine—ADRA2C—spinal cord—malignant glioma	0.00242	0.00475	CbGeAlD
Methotrimeprazine—CYP2D6—brainstem—malignant glioma	0.00241	0.00472	CbGeAlD
Methotrimeprazine—HTR2A—telencephalon—malignant glioma	0.00234	0.0046	CbGeAlD
Methotrimeprazine—CHRM3—central nervous system—malignant glioma	0.00224	0.0044	CbGeAlD
Methotrimeprazine—Ethopropazine—BCHE—malignant glioma	0.0022	0.0931	CrCbGaD
Methotrimeprazine—CHRM2—brain—malignant glioma	0.00219	0.00429	CbGeAlD
Methotrimeprazine—ADRA2A—medulla oblongata—malignant glioma	0.00217	0.00425	CbGeAlD
Methotrimeprazine—CYP2D6—telencephalon—malignant glioma	0.00214	0.00419	CbGeAlD
Methotrimeprazine—CYP2E1—medulla oblongata—malignant glioma	0.00212	0.00416	CbGeAlD
Methotrimeprazine—HTR2C—brain—malignant glioma	0.00211	0.00414	CbGeAlD
Methotrimeprazine—ADRA1A—central nervous system—malignant glioma	0.00206	0.00404	CbGeAlD
Methotrimeprazine—DRD2—central nervous system—malignant glioma	0.00202	0.00396	CbGeAlD
Methotrimeprazine—ADRA1A—cerebellum—malignant glioma	0.00201	0.00395	CbGeAlD
Methotrimeprazine—CHRM1—brain—malignant glioma	0.00199	0.00391	CbGeAlD
Methotrimeprazine—ADRA2A—midbrain—malignant glioma	0.00198	0.00388	CbGeAlD
Methotrimeprazine—DRD2—cerebellum—malignant glioma	0.00197	0.00387	CbGeAlD
Methotrimeprazine—ADRA2C—central nervous system—malignant glioma	0.00196	0.00385	CbGeAlD
Methotrimeprazine—ADRA2A—spinal cord—malignant glioma	0.00193	0.00379	CbGeAlD
Methotrimeprazine—ADRA2C—cerebellum—malignant glioma	0.00192	0.00377	CbGeAlD
Methotrimeprazine—CYP2E1—spinal cord—malignant glioma	0.00189	0.00371	CbGeAlD
Methotrimeprazine—Clomipramine—GSTP1—malignant glioma	0.00185	0.0781	CrCbGaD
Methotrimeprazine—HTR2A—medulla oblongata—malignant glioma	0.00184	0.00361	CbGeAlD
Methotrimeprazine—Perphenazine—CYP2C18—malignant glioma	0.00181	0.0765	CrCbGaD
Methotrimeprazine—Triflupromazine—BCHE—malignant glioma	0.0018	0.0763	CrCbGaD
Methotrimeprazine—CHRM3—brain—malignant glioma	0.00178	0.0035	CbGeAlD
Methotrimeprazine—HTR2A—midbrain—malignant glioma	0.00168	0.0033	CbGeAlD
Methotrimeprazine—HTR2A—spinal cord—malignant glioma	0.00164	0.00322	CbGeAlD
Methotrimeprazine—ADRA1A—brain—malignant glioma	0.00164	0.00321	CbGeAlD
Methotrimeprazine—DRD2—brain—malignant glioma	0.0016	0.00315	CbGeAlD
Methotrimeprazine—HRH1—central nervous system—malignant glioma	0.0016	0.00313	CbGeAlD
Methotrimeprazine—ADRA2A—central nervous system—malignant glioma	0.00157	0.00307	CbGeAlD
Methotrimeprazine—ADRA2C—brain—malignant glioma	0.00156	0.00306	CbGeAlD
Methotrimeprazine—CYP2E1—central nervous system—malignant glioma	0.00153	0.00301	CbGeAlD
Methotrimeprazine—ADRA2A—cerebellum—malignant glioma	0.00153	0.003	CbGeAlD
Methotrimeprazine—CYP2E1—cerebellum—malignant glioma	0.0015	0.00294	CbGeAlD
Methotrimeprazine—Imipramine—CYP2C18—malignant glioma	0.00143	0.0604	CrCbGaD
Methotrimeprazine—Promethazine—CYP2B6—malignant glioma	0.00138	0.0582	CrCbGaD
Methotrimeprazine—Perphenazine—CYP2B6—malignant glioma	0.00134	0.0568	CrCbGaD
Methotrimeprazine—HTR2A—central nervous system—malignant glioma	0.00133	0.00261	CbGeAlD
Methotrimeprazine—HTR2A—cerebellum—malignant glioma	0.0013	0.00255	CbGeAlD
Methotrimeprazine—HRH1—brain—malignant glioma	0.00127	0.00248	CbGeAlD
Methotrimeprazine—ADRA2A—brain—malignant glioma	0.00124	0.00244	CbGeAlD
Methotrimeprazine—Trimipramine—SLC6A3—malignant glioma	0.00122	0.0515	CrCbGaD
Methotrimeprazine—CYP2E1—brain—malignant glioma	0.00122	0.00239	CbGeAlD
Methotrimeprazine—CYP2D6—central nervous system—malignant glioma	0.00121	0.00238	CbGeAlD
Methotrimeprazine—CYP2D6—cerebellum—malignant glioma	0.00119	0.00233	CbGeAlD
Methotrimeprazine—Imipramine—CYP2B6—malignant glioma	0.00106	0.0448	CrCbGaD
Methotrimeprazine—HTR2A—brain—malignant glioma	0.00106	0.00208	CbGeAlD
Methotrimeprazine—CYP2D6—brain—malignant glioma	0.000964	0.00189	CbGeAlD
Methotrimeprazine—Imipramine—SLC6A3—malignant glioma	0.000903	0.0382	CrCbGaD
Methotrimeprazine—Chlorpromazine—BCHE—malignant glioma	0.00087	0.0368	CrCbGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CASP3—malignant glioma	2.52e-05	5.4e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—ERBB2—malignant glioma	2.52e-05	5.4e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	2.52e-05	5.4e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL2—malignant glioma	2.52e-05	5.39e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—ERBB2—malignant glioma	2.51e-05	5.39e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—AKT1—malignant glioma	2.51e-05	5.39e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	2.51e-05	5.38e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MDM2—malignant glioma	2.51e-05	5.38e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—AKT1—malignant glioma	2.51e-05	5.38e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—ERBB2—malignant glioma	2.51e-05	5.37e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MDM2—malignant glioma	2.5e-05	5.36e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—RAF1—malignant glioma	2.5e-05	5.36e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—ERBB2—malignant glioma	2.5e-05	5.35e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—RAF1—malignant glioma	2.49e-05	5.34e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MMP9—malignant glioma	2.49e-05	5.33e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	2.49e-05	5.33e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—FGF2—malignant glioma	2.48e-05	5.33e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PIK3CB—malignant glioma	2.48e-05	5.32e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	2.48e-05	5.32e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—PTEN—malignant glioma	2.47e-05	5.3e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	2.47e-05	5.3e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	2.47e-05	5.3e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—EGFR—malignant glioma	2.47e-05	5.29e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	2.47e-05	5.29e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—KRAS—malignant glioma	2.47e-05	5.29e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	2.46e-05	5.28e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTGS2—malignant glioma	2.46e-05	5.27e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	2.44e-05	5.23e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	2.43e-05	5.22e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—KRAS—malignant glioma	2.43e-05	5.22e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CXCL8—malignant glioma	2.43e-05	5.2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MMP9—malignant glioma	2.42e-05	5.19e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	2.41e-05	5.17e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—PTEN—malignant glioma	2.41e-05	5.16e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MYC—malignant glioma	2.4e-05	5.15e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	2.39e-05	5.12e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CXCL8—malignant glioma	2.38e-05	5.11e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MMP9—malignant glioma	2.38e-05	5.11e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CXCL8—malignant glioma	2.38e-05	5.09e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MYC—malignant glioma	2.37e-05	5.08e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MYC—malignant glioma	2.37e-05	5.08e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CXCL8—malignant glioma	2.37e-05	5.08e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—PTEN—malignant glioma	2.37e-05	5.08e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—EGFR—malignant glioma	2.35e-05	5.04e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	2.35e-05	5.03e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	2.35e-05	5.03e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	2.35e-05	5.03e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	2.34e-05	5.01e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PTEN—malignant glioma	2.34e-05	5.01e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	2.33e-05	5e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—KRAS—malignant glioma	2.33e-05	4.99e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—VEGFA—malignant glioma	2.33e-05	4.99e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MDM2—malignant glioma	2.32e-05	4.98e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CASP3—malignant glioma	2.32e-05	4.98e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL2—malignant glioma	2.32e-05	4.97e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—EGFR—malignant glioma	2.32e-05	4.97e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—EGFR—malignant glioma	2.32e-05	4.97e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—RAF1—malignant glioma	2.32e-05	4.97e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	2.31e-05	4.95e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	2.31e-05	4.95e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—STAT3—malignant glioma	2.3e-05	4.94e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	2.3e-05	4.94e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3CG—malignant glioma	2.3e-05	4.93e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	2.3e-05	4.92e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	2.29e-05	4.91e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	2.29e-05	4.9e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CASP3—malignant glioma	2.29e-05	4.9e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL2—malignant glioma	2.28e-05	4.89e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CASP3—malignant glioma	2.28e-05	4.89e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL2—malignant glioma	2.28e-05	4.88e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CASP3—malignant glioma	2.27e-05	4.87e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL2—malignant glioma	2.27e-05	4.87e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CASP3—malignant glioma	2.27e-05	4.86e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—PIK3CA—malignant glioma	2.27e-05	4.86e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	2.27e-05	4.86e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL2—malignant glioma	2.26e-05	4.85e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	2.26e-05	4.85e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	2.26e-05	4.84e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CASP3—malignant glioma	2.24e-05	4.81e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL2—malignant glioma	2.24e-05	4.8e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	2.24e-05	4.8e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—PIK3CA—malignant glioma	2.24e-05	4.79e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL2—malignant glioma	2.24e-05	4.79e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	2.23e-05	4.79e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—KRAS—malignant glioma	2.22e-05	4.76e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PPARG—malignant glioma	2.22e-05	4.76e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—STAT3—malignant glioma	2.21e-05	4.74e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MMP9—malignant glioma	2.2e-05	4.71e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TP53—malignant glioma	2.19e-05	4.7e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—KRAS—malignant glioma	2.19e-05	4.7e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—KRAS—malignant glioma	2.19e-05	4.7e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PTEN—malignant glioma	2.18e-05	4.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	2.17e-05	4.66e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	2.17e-05	4.66e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TP53—malignant glioma	2.16e-05	4.64e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MMP9—malignant glioma	2.16e-05	4.63e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MMP9—malignant glioma	2.16e-05	4.62e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—STAT3—malignant glioma	2.15e-05	4.61e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MMP9—malignant glioma	2.15e-05	4.61e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PTEN—malignant glioma	2.15e-05	4.6e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTEN—malignant glioma	2.15e-05	4.6e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PTEN—malignant glioma	2.14e-05	4.59e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MMP9—malignant glioma	2.14e-05	4.59e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	2.14e-05	4.59e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MYC—malignant glioma	2.14e-05	4.59e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CAV1—malignant glioma	2.14e-05	4.59e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	2.14e-05	4.58e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PTEN—malignant glioma	2.14e-05	4.58e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—AKT1—malignant glioma	2.13e-05	4.57e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PTEN—malignant glioma	2.13e-05	4.57e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MMP9—malignant glioma	2.12e-05	4.55e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—STAT3—malignant glioma	2.12e-05	4.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	2.12e-05	4.53e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PTEN—malignant glioma	2.11e-05	4.52e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	2.1e-05	4.51e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	2.1e-05	4.5e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	2.1e-05	4.49e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—EGFR—malignant glioma	2.09e-05	4.49e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—AKT1—malignant glioma	2.09e-05	4.48e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—AKT1—malignant glioma	2.08e-05	4.47e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CASP3—malignant glioma	2.08e-05	4.46e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—AKT1—malignant glioma	2.08e-05	4.45e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL2—malignant glioma	2.08e-05	4.45e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TP53—malignant glioma	2.07e-05	4.44e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	2.06e-05	4.41e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MYC—malignant glioma	2.06e-05	4.41e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	2.05e-05	4.4e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.04e-05	4.38e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—PIK3CA—malignant glioma	2.04e-05	4.37e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PIK3CA—malignant glioma	2.03e-05	4.35e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.02e-05	4.33e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—PIK3CA—malignant glioma	2.01e-05	4.31e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	2.01e-05	4.31e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—EGFR—malignant glioma	2.01e-05	4.31e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MYC—malignant glioma	2e-05	4.29e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—KRAS—malignant glioma	1.98e-05	4.24e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TP53—malignant glioma	1.97e-05	4.23e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—VEGFA—malignant glioma	1.97e-05	4.23e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MYC—malignant glioma	1.97e-05	4.22e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MMP9—malignant glioma	1.97e-05	4.21e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—EGFR—malignant glioma	1.96e-05	4.19e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PTEN—malignant glioma	1.95e-05	4.19e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—STAT3—malignant glioma	1.95e-05	4.18e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.95e-05	4.18e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TP53—malignant glioma	1.95e-05	4.17e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TP53—malignant glioma	1.95e-05	4.17e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	1.94e-05	4.16e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—VEGFA—malignant glioma	1.94e-05	4.15e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—VEGFA—malignant glioma	1.93e-05	4.14e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—EGFR—malignant glioma	1.92e-05	4.13e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—VEGFA—malignant glioma	1.92e-05	4.12e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—STAT3—malignant glioma	1.92e-05	4.12e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—STAT3—malignant glioma	1.92e-05	4.11e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—STAT3—malignant glioma	1.91e-05	4.1e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	1.91e-05	4.09e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	1.9e-05	4.08e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—STAT3—malignant glioma	1.9e-05	4.08e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	1.9e-05	4.07e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—KRAS—malignant glioma	1.9e-05	4.07e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—STAT3—malignant glioma	1.89e-05	4.04e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	1.88e-05	4.03e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PPARG—malignant glioma	1.88e-05	4.03e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—AKT1—malignant glioma	1.85e-05	3.97e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—KRAS—malignant glioma	1.85e-05	3.96e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—AKT1—malignant glioma	1.83e-05	3.91e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—KRAS—malignant glioma	1.82e-05	3.9e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—PIK3CA—malignant glioma	1.82e-05	3.89e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MYC—malignant glioma	1.81e-05	3.89e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PIK3CA—malignant glioma	1.8e-05	3.85e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MYC—malignant glioma	1.79e-05	3.83e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MYC—malignant glioma	1.78e-05	3.82e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MYC—malignant glioma	1.78e-05	3.81e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—EGFR—malignant glioma	1.77e-05	3.8e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MYC—malignant glioma	1.77e-05	3.79e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	1.77e-05	3.78e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.76e-05	3.78e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TP53—malignant glioma	1.76e-05	3.77e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MYC—malignant glioma	1.75e-05	3.76e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—AKT1—malignant glioma	1.75e-05	3.75e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MYC—malignant glioma	1.75e-05	3.75e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—STAT3—malignant glioma	1.75e-05	3.75e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTGS2—malignant glioma	1.75e-05	3.74e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—EGFR—malignant glioma	1.75e-05	3.74e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	1.75e-05	3.74e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—EGFR—malignant glioma	1.74e-05	3.73e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—EGFR—malignant glioma	1.74e-05	3.72e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—EGFR—malignant glioma	1.73e-05	3.71e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—EGFR—malignant glioma	1.71e-05	3.67e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.71e-05	3.67e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	1.71e-05	3.66e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	1.7e-05	3.64e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TP53—malignant glioma	1.69e-05	3.62e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—KRAS—malignant glioma	1.68e-05	3.59e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	1.67e-05	3.58e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—AKT1—malignant glioma	1.67e-05	3.57e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—AKT1—malignant glioma	1.66e-05	3.55e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—KRAS—malignant glioma	1.65e-05	3.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PIK3CA—malignant glioma	1.65e-05	3.53e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—KRAS—malignant glioma	1.65e-05	3.53e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—AKT1—malignant glioma	1.64e-05	3.52e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—AKT1—malignant glioma	1.64e-05	3.52e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TP53—malignant glioma	1.64e-05	3.52e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—KRAS—malignant glioma	1.64e-05	3.52e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—KRAS—malignant glioma	1.64e-05	3.51e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MYC—malignant glioma	1.62e-05	3.48e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—KRAS—malignant glioma	1.62e-05	3.47e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TP53—malignant glioma	1.62e-05	3.46e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	1.62e-05	3.46e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—EGFR—malignant glioma	1.59e-05	3.4e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	1.54e-05	3.3e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTEN—malignant glioma	1.52e-05	3.26e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	1.52e-05	3.25e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PIK3CA—malignant glioma	1.51e-05	3.25e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	1.51e-05	3.24e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	1.51e-05	3.23e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	1.5e-05	3.22e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—KRAS—malignant glioma	1.5e-05	3.22e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.49e-05	3.2e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TP53—malignant glioma	1.49e-05	3.19e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	1.49e-05	3.19e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—AKT1—malignant glioma	1.48e-05	3.18e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	1.48e-05	3.18e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTGS2—malignant glioma	1.48e-05	3.17e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—AKT1—malignant glioma	1.47e-05	3.15e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TP53—malignant glioma	1.47e-05	3.14e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TP53—malignant glioma	1.46e-05	3.14e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TP53—malignant glioma	1.46e-05	3.13e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TP53—malignant glioma	1.45e-05	3.12e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TP53—malignant glioma	1.44e-05	3.09e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TP53—malignant glioma	1.44e-05	3.08e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—AKT1—malignant glioma	1.43e-05	3.06e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—AKT1—malignant glioma	1.39e-05	2.97e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	1.38e-05	2.96e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—AKT1—malignant glioma	1.36e-05	2.93e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—AKT1—malignant glioma	1.35e-05	2.89e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TP53—malignant glioma	1.33e-05	2.86e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTEN—malignant glioma	1.29e-05	2.77e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—AKT1—malignant glioma	1.26e-05	2.7e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—AKT1—malignant glioma	1.24e-05	2.65e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—AKT1—malignant glioma	1.24e-05	2.65e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—AKT1—malignant glioma	1.24e-05	2.65e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—AKT1—malignant glioma	1.23e-05	2.64e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—AKT1—malignant glioma	1.23e-05	2.63e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—AKT1—malignant glioma	1.22e-05	2.61e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	1.21e-05	2.6e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—AKT1—malignant glioma	1.13e-05	2.41e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.07e-05	2.3e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CA—malignant glioma	9.1e-06	1.95e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—AKT1—malignant glioma	8.78e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—AKT1—malignant glioma	7.44e-06	1.59e-05	CbGpPWpGaD
